日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism

更正:通过靶向葡萄糖代谢相关的下游信号通路,增强FGFR1抑制剂在鳞状细胞肺癌中的抗肿瘤活性

Fumarola, Claudia; Cretella, Daniele; Monica, Silvia La; Bonelli, Mara A; Alfieri, Roberta; Caffarra, Cristina; Quaini, Federico; Madeddu, Denise; Falco, Angela; Cavazzoni, Andrea; Digiacomo, Graziana; Mazzaschi, Giulia; Vivo, Valentina; Barocelli, Elisabetta; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea

Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

更正:CDK4/6抑制剂与PI3K/AKT/mTOR抑制剂联合使用,可通过损害TNBC细胞的葡萄糖代谢来增强其抗肿瘤疗效。

Cretella, Daniele; Ravelli, Andrea; Fumarola, Claudia; La Monica, Silvia; Digiacomo, Graziana; Cavazzoni, Andrea; Alfieri, Roberta; Biondi, Alessandra; Generali, Daniele; Bonelli, Mara; Petronini, Pier Giorgio

Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments

抗血管生成酪氨酸激酶抑制剂在肾细胞癌模型中的免疫调节作用:对后续抗 PD-1 治疗的影响

Claudia Fumarola, Silvia La Monica, Mara Bonelli, Silvia Zoppi, Roberta Alfieri, Maricla Galetti, Letizia Gnetti, Nicoletta Campanini, Giulia Pozzi, Andrea Cavazzoni, Giulia Mazzaschi, Enrico Maria Silini, Sebastiano Buti, Pier Giorgio Petronini

Targeting glucosylceramide synthase induces antiproliferative and proapoptotic effects in osimertinib-resistant NSCLC cell models

靶向葡萄糖神经酰胺合酶可在奥希替尼耐药 NSCLC 细胞模型中诱导抗增殖和促凋亡作用

Silvia La Monica #, Federica Vacondio #, Kamal Eltayeb, Alessio Lodola, Francesco Volta, Martina Viglioli, Francesca Ferlenghi, Francesca Galvani, Maricla Galetti, Mara Bonelli, Claudia Fumarola, Andrea Cavazzoni, Lisa Flammini, Michela Verzè, Roberta Minari, Pier Giorgio Petronini, Marcello Tiseo, 

Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells

更正:CDK4/6抑制剂可提高乐伐替尼在肝癌细胞中的抗肿瘤疗效

Digiacomo, Graziana; Fumarola, Claudia; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Galetti, Maricla; Terenziani, Rita; Eltayeb, Kamal; Volta, Francesco; Zoppi, Silvia; Bertolini, Patrizia; Missale, Gabriele; Alfieri, Roberta; Petronini, Pier Giorgio

Critical Issues in Assessing Occupational Exposure to Diesel Dust Exhaust

评估职业暴露于柴油机尾气粉尘暴露的关键问题

Folesani, Giuseppina; Gherardi, Monica; Galetti, Maricla; Petronini, Pier Giorgio; De Pasquale, Fabrizio; Cavallo, Delia; Corradi, Massimo

A Photoactive Supramolecular Complex Targeting PD-L1 Reveals a Weak Correlation between Photoactivation Efficiency and Receptor Expression Levels in Non-Small-Cell Lung Cancer Tumor Models

靶向 PD-L1 的光活性超分子复合物揭示非小细胞肺癌肿瘤模型中的光激活效率与受体表达水平之间存在弱相关性

Pietro Delcanale, Manuela Maria Alampi, Andrea Mussini, Claudia Fumarola, Maricla Galetti, Pier Giorgio Petronini, Cristiano Viappiani, Stefano Bruno, Stefania Abbruzzetti

Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators

EGFR突变型非小细胞肺癌细胞系对奥希替尼的固有耐药性是由细胞周期调节因子的改变引起的

Volta, Francesco; La Monica, Silvia; Leonetti, Alessandro; Gnetti, Letizia; Bonelli, Mara; Cavazzoni, Andrea; Fumarola, Claudia; Galetti, Maricla; Eltayeb, Kamal; Minari, Roberta; Petronini, Pier Giorgio; Tiseo, Marcello; Alfieri, Roberta

A New ABCB1 Inhibitor Enhances the Anticancer Effect of Doxorubicin in Both In Vitro and In Vivo Models of NSCLC

新型 ABCB1 抑制剂可增强阿霉素在 NSCLC 体内和体外模型中的抗癌作用

Maria Pia Adorni, Maricla Galetti, Silvia La Monica, Matteo Incerti, Alessandro Ruffoni, Lisa Elviri, Ilaria Zanotti, Bianca Papotti, Delia Cavallo, Roberta Alfieri, Pier Giorgio Petronini, Franco Bernini

Interaction between Occupational and Non-Occupational Arsenic Exposure and Tobacco Smoke on Lung Cancerogenesis: A Systematic Review

职业性和非职业性砷暴露与烟草烟雾对肺癌发生的影响:系统评价

Folesani, Giuseppina; Galetti, Maricla; Petronini, Pier Giorgio; Mozzoni, Paola; La Monica, Silvia; Cavallo, Delia; Corradi, Massimo